These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3536537)

  • 21. [Immunologic parameters in insulin-dependent diabetes mellitus in children].
    Strnová J; Páleníková O; Horváthová J; Getlík A
    Cesk Pediatr; 1990 Jan; 45(1):16-7. PubMed ID: 2203546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of autoimmune type I diabetes in biobreeding (BB) rats by a newly established, autoreactive T cell line from acutely diabetic BB rats.
    Nagata M; Yoon JW
    J Immunol; 1994 Oct; 153(8):3775-83. PubMed ID: 7930594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of cells responsible for the suppression of anti-beta-cell cytotoxicity in type I (insulin-dependent) diabetes mellitus.
    Krug J; Bierwolf B; Lampeter E; Verlohren HJ; Lohmann D
    Clin Exp Immunol; 1991 Apr; 84(1):43-7. PubMed ID: 1826646
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro model for cellular cytotoxicity against rat Langerhans' islets. Protective effect of mouse interferon on rat target cells.
    Farkas G; Pusztai R; Mándi Y; Béládi I
    Transplantation; 1983 Nov; 36(5):583-4. PubMed ID: 6195787
    [No Abstract]   [Full Text] [Related]  

  • 25. Cell-mediated immune reactions against B cells and defect of suppressor cell activity in type 1 (insulin-dependent) diabetes mellitus.
    Lohmann D; Krug J; Lampeter EF; Bierwolf B; Verlohren HJ
    Diabetologia; 1986 Jul; 29(7):421-5. PubMed ID: 2943624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of sera obtained from children with insulin-dependent diabetes mellitus on cultivated islet cells: cytotoxicity and insulin release.
    Sadovnikova NV; Pankov YA; Fedotov VP; Czernushkina AV; Zhukovsky MA; Shcherbacheva LN
    Exp Clin Endocrinol; 1989 May; 93(2-3):166-72. PubMed ID: 2673810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ciamexone suppressed anti-islet ADCC of mononuclear cells and serum from type 1 (insulin-dependent) diabetic patients.
    Köhler E; Knospe S; Hahn HJ; Roemer KG; Diamantstein T
    Exp Clin Endocrinol; 1989 May; 93(2-3):143-6. PubMed ID: 2673806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absence of cytotoxicity of islet cell surface antibodies in vivo despite complement-mediated cytotoxic effects to islet cells in vitro.
    Kohnert KD; Hehmke B; Fält K; Ziegler M
    Biomed Biochim Acta; 1984; 43(5):663-73. PubMed ID: 6206850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement-dependent antibody-mediated cytotoxicity in the spontaneously diabetic BB/OK rat: association with beta cell volume density.
    Hehmke B; Lucke S; Schröder D; Klöting I; Kohnert KD
    Eur J Immunol; 1990 May; 20(5):1091-6. PubMed ID: 2192902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro lysis of islet cells by lymphocytes from diabetic BB/Wor rats is not antibody mediated.
    Koevary SB
    Diabetes Res; 1990 Mar; 13(3):133-8. PubMed ID: 2091881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electron microscopical investigations on lymphocyte cytotoxicity against beta-cells in recent onset IDDM.
    Lampeter E; Bierwolf B; Krug J; Verlohren HJ; Lohmann D; Cossel L
    Diabetes Res; 1987 Dec; 6(4):159-67. PubMed ID: 3329076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous biochemical and morphological investigations on the effect of leukocytes from type I diabetics on isolated rat islets.
    Lampeter EF; Bierwolf B; Lohmann D; Wohlrab F; Cossel L
    Biomed Biochim Acta; 1984; 43(5):647-56. PubMed ID: 6383369
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of azathioprine, cyclosporine A and insulin on the in vitro lymphocyte-mediated cytotoxicity in type I diabetic patients.
    Horváth M; Varsányi M; Bándi E; Balázsi I; Romics L
    Exp Clin Endocrinol; 1992; 100(3):90-4. PubMed ID: 1305069
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunological disorder in diabetes mellitus].
    Takeuchi K; Jodo S; Koike T
    Nihon Rinsho; 1997 Oct; 55 Suppl():700-4. PubMed ID: 9392184
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunotherapy in type 1 diabetes: present status.
    Pozzilli P; Kolb H
    Immunol Today; 1989 Oct; 10(10):321-2. PubMed ID: 2679628
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical review 17: Immunotherapy of type I diabetes mellitus.
    Marks JB; Skyler JS
    J Clin Endocrinol Metab; 1991 Jan; 72(1):3-9. PubMed ID: 1986025
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunotherapy of insulin-dependent diabetes mellitus].
    Satoh J; Seino H; Shintani S; Toyota T
    Nihon Rinsho; 1991 Feb; 49 Suppl():519-24. PubMed ID: 2033845
    [No Abstract]   [Full Text] [Related]  

  • 38. Immunospecific therapy for type I diabetes mellitus.
    Culler FL; O'Connor R; Kaufmann S; Jones KL; Roth JC
    N Engl J Med; 1985 Sep; 313(11):695-6. PubMed ID: 3875034
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunotherapy in pre-type 1 diabetes mellitus.
    Bach JF; Dupré J; Eisenbarth GS; Harrison LC; Maclaren NK; Nerup J; Pozzilli P
    Diabetologia; 1990 Dec; 33(12):741. PubMed ID: 2073989
    [No Abstract]   [Full Text] [Related]  

  • 40. Buffy coat transfusions in early type I diabetes.
    Cavanaugh J; Chopek M; Binimelis J; Leiva A; Barbosa J
    Diabetes; 1987 Oct; 36(10):1089-93. PubMed ID: 3308579
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.